Tekla Capital Management LLC Repare Therapeutics Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 29,150 shares of RPTX stock, worth $100,276. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,150
Previous 29,150
-0.0%
Holding current value
$100,276
Previous $286,000
7.69%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
69Shares Held
36.8MCall Options Held
51.7KPut Options Held
17.7K-
Bvf Inc San Francisco, CA10.3MShares$35.5 Million1.04% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$11.6 Million4.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$11.4 Million0.26% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$10.2 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$9.1 Million19.39% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $144M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...